TVEC
3 abstracts
Abstract
SH2B3 mutation as a potential resistance mechanism to oncolytic virus therapy.Org: Yale New Haven Hospital, Yale School of Medicine,
Abstract
Association between genomic alterations and response of triple-negative breast cancers (TNBC) to talimogene laherparepvec (TVEC) in combination with neoadjuvant chemotherapy (NACT).Org: H. Lee Moffitt Cancer Center and Research Institute, Moffitt Cancer Center and Research Institute, Moffitt Cancer Center,